ValueQ3, 24Q4, 24Q1, 25Q2, 25Q3, 25TTMSelling/general/admin expenses2.24 M2.65 M1.74 M2.12 M1.57 M8.09 MResearch & development24 K13 K09 000022 KOperating income1.76 M-1.68 M530 K501 K1.15 M503 KNon-Operating Income, Total15 K-137 K01.07 M1.7 M2.63 MInterest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses000000Unusual income/expense15 K-137 K01.07 M1.7 M2.63 MPretax income1.18 M7.03 M530 K1.57 M2.85 M11.98 MEquity in earnings——————Taxes0—————Non-controlling/minority interest0-10 K————After tax other income/expense——————Net income before discontinued operations1.61 M1.94 M2.6 M4.46 M856 K9.86 MDiscontinued operations——000—Net income1.61 M1.94 M2.6 M4.46 M856 K9.86 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders1.61 M1.94 M2.6 M4.46 M856 K9.86 MBasic earnings per share (Basic EPS)-1.18-2.991.9-3.260.63-3.72Diluted earnings per share (Diluted EPS)-1.18-2.991.9-3.260.62-3.73Average basic shares outstanding1.36 M1.36 M1.37 M1.37 M1.37 M5.46 MDiluted shares outstanding1.36 M1.36 M1.37 M1.37 M1.37 M5.47 MEBITDA-1.54 M-1.94 M-250 K-1.48 M-1.14 M-4.81 MEBIT-1.55 M-1.93 M-263 K-1.49 M-1.15 M-4.83 MCost of revenue1.03 M827 K682 K824 K884 K3.22 MOther cost of goods sold154 K0——0—Depreciation & amortization (cash flow)7 000-17 K13 K15 K2 00013 K
Arcadia Biosciences Inc
Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.